2nd Quarter - Report
GARY BUEHLER for TEVA PHARMACEUTICALS USA, INC.
Firm
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Section 505(b)(2) new drug applications and exclusivity period.
Foreign entity interest: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issue(s) listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY BUEHLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.